Saturday, July 11, 2026

pharma · Leukemia, Lymphocytic, Acute, B-Cell · Prostate Cancer Indications

Shenzhen Second People's

News and analysis for Shenzhen Second People's on NovaPharmaNews — regulatory, clinical, and market coverage.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
2
Drugs
4
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Shenzhen Second People's — regulatory, clinical, and market coverage.

News and analysis for Shenzhen Second People's on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Shenzhen Second People's yet.

Back to company overview →